Category: District of Delaware
-
Novo Nordisk suffers loss over negative claim limitation in ongoing patent dispute over diabetes drug Wegovy
The United States District Court for the District of Delaware has ruled that Viatris has not induced the infringement of one of five asserted patents in litigation initiated by Novo Nordisk.
-
U.S. appeals court grants Novartis short-term injunction in Entresto patent dispute with MSN: non-skilled-artisan testimony is key issue
The Federal Circuit has granted Novartis a few more days of Entresto exclusivity through a short-term injunction against MSN.
-
Walkie-Talkie maker Voxer sues Amazon, Twitch over video communication patents: previously prevailed over Meta
Voxer previously settled a major patent infringement dispute over similar video communication technologies with Meta in February 2024, after being awarded damages of over $206 million.
-
Novartis denied injunctive relief against MSN in chronic heart failure patent fight: next stop emergency motion for injunction pending appeal?
Novartis cannot block rival MSN Pharmaceuticals from launching a generic version of its chronic heart failure treatment Entresto before its patent expires in November 2026, the District of Delaware has held.